Autologous transplant: Microbial contamination of hematopoietic stem cell products

Brazilian Journal of Infectious Diseases

Volumn 16, Issue 4, 2012, Pages 345-350

  Dullius Almeida, Igor ^a   Schmalfuss, Tissiana ^a   Röhsig, Liane Marise ^a   Zubaran Goldani, Luciano ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Autologous transplant; Bacterial contamination; Hematopoietic stem cell products; Microbial contamination; Quality control

Indexed keywords

ACTIVATED CARBON; AMIKACIN; AMPICILLIN; CEFEPIME; CIPROFLOXACIN; CLINDAMYCIN; GENTAMICIN; NORFLOXACIN; OXACILLIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BACTERIUM ISOLATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; GENERAL DEVICE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN TISSUE; INFUSION; MICROBIAL CONTAMINATION; MICROBIAL IDENTIFICATION; MICROBIOLOGICAL EXAMINATION; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; TRANSFUSION;

ADULT; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TRANSPLANTATION, AUTOLOGOUS;

EID: 84864342308     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2012.06.012     Document Type: Article

References (21)

1. Hirji Z., Saragosa R., Dedier H., et al. Contamination of bone marrow products with an actinomycete resembling Microbacterium species and reinfusion into autologous stem cell and bone marrow transplant recipients. Clin Infect Dis 2003, 36:115-121.
2. Naoum F.A., Martins L.T.V., Castro N.S., Barros J.C., Chiattone C.S. Perfil microbiológico dos pacientes nos primeiros trinta dias após transplante de medula óssea do Serviço de Transplantes da Santa Casa de São Paulo. Rev Bras Hematol Hemoter 2002, 24:91-96.
3. Larrea L., de la Rubia J., Soler M.A., et al. Quality control of bacterial contamination in autologous peripheral blood stem cells for transplantation. Haematologica 2004, 89:1232-1237.
4. Aksu G., Ruhi M.Z., Akan H., et al. Aerobic bacterial and fungal infections in peripheral blood stem cell transplants. Bone Marrow Transplant 2001, 27:201-205.
5. Kamble R., Pant S., Selby G.B., et al. Microbial contamination of hematopoietic progenitor cell grafts-incidence, clinical outcome, and cost-effectiveness: an analysis of 735 grafts. Transfusion 2005, 45:874-878.
6. Kipp F., Linnemann E., Fischer R.J., Sibrowski W., Cassens U. Cryopreservation reduces the concentration of detectable bacteria in contaminated peripheral blood progenitor cell products. Transfusion 2004, 44:1098-1103.
7. Patah P.A., Parmar S., McMannis J., et al. Microbial contamination of hematopoietic progenitor cell products: clinical outcome. Bone Marrow Transplantation 2007, 40:365-368.
8. Lowder J.N., Whelton P. Microbial contamination of cellular products for hematolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impact. Cytother 2003, 5:377-390.
9. Jestice H.K., Farrington M., Hunt C., et al. Bacterial contamination of peripheral blood progenitor cells for transplantation. Transfus Med 1996, 6:103-110.
10. Padley D., Koontz F., Trigg M.E., Gingrich R., Strauss R.G. Bacterial contamination rates following processing of bone marrow and peripheral blood progenitor cell preparations. Transfusion 1996, 36:53-56.
11. Ritter M., Schwedler J., Beyer J., et al. Bacterial contamination of ex vivo processed PBPC products under clean room conditions. Transfusion 2003, 43:1587-1595.
12. Schwella N., Rick O., Heuft H.G., et al. Bacterial contamination of autologous bone marrow: reinfusion of culture-positive grafts does not result in clinical sequelae during the posttransplantation course. Vox Sang 1998, 74:88-94.
13. Cassens U., Ahlke C., Garritsen H., et al. Processing of peripheral blood progenitor cell components in improved clean areas does not reduce the rate of microbial contamination. Transfusion 2002, 42:10-17.
14. Nifong T.P., Ehmann C., Mierski J.A., Domen R.E., Rybka W.B. Favorable outcome after infusion of coagulase-negative Staphylococci- contaminated peripheral blood hematopoietic cells for autologous transplantation. Arch Pathol Lab Med 2003, 127:e19-e21.
15. Padley D.J., Greiner C.W., Heddlesten-Rediske T.L., Hopkins M.K., Maas M.L., Gastineau D.A. Endogenous microbial contamination of cultured autologous preparations in trials of cancer immunotherapy. Cytotherapy 2003, 5:147-152.
16. Prince H.M., Page S.R., Keating A., et al. Microbial contamination of harvested bone marrow and peripheral blood. Bone Marrow Transplant 1995, 15:87-91.
17. Webb I.J., Coral P.S., Andersen J.W. Sources and sequeale of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering. Transfusion 1996, 36:782-788.
18. Nasser R.M., Hajjar I., Sandhaus L.M., et al. Routine cultures of bone marrow and peripheral stem cell harvests: clinical impact, cost analysis, and review. Clin Infect Dis 1998, 27:886-888.
19. Padley D.J., Dietz A.B., Gastineau D.A. Sterility testing of hematopoietic progenitor cell products: a single-institution series of culture-positive rates and successful infusion of culture-positive products. Transfusion 2007, 47:636-643.
20. Klein M.A., Kadidlo D., McCullough J., McKenna D.H., Burns L.F. Microbial contamination of hematopoietic stem cell products: Incidence and clinical sequelae. Biol Blood and Marrow Transplant 2006, 12:1142-1149.
21. Mele L., Dallavalle F.M., Verri G., et al. Safety control of peripheral blood progenitor cell processing- eight year-survey of microbiological contamination and bag ruptures in a single institution. Transfus Apher Sci 2005, 33:269-274.